Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valganciclovir for Prevention of IRIS-KS in Disseminated Kaposi Sarcoma
NCT03296553Phase 2Completed
- Sponsor
- Instituto Nacional de Cancerología
- Start
- Oct 2015
- Primary completion
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of valganciclovir in Kaposi sarcoma (KS), sponsored by Instituto Nacional de Cancerología. Started Oct 2015; status: completed.
02
Drugs
valganciclovir
03
Conditions
Kaposi sarcoma (KS)
Beyond the preview
Go deeper on NCT03296553.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03296553.